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Introduction
Diagnosis of inflammatory bowel disease is based on clinical presentation, endoscopy, histopathological findings, and various other imaging techniques. [1] While the investigation of the small bowel has been difficult for years, only recently have two methods been introduced which may overcome the considerable limitations of conventional fluoroscopy. Capsule endoscopy (CE) [2] offers direct visualization of the small bowel mucosa, and magnetic resonance imaging (MRI) enables accurate diagnosis of intestinal and extra-intestinal abdominal pathology. [3] [4] In small bowel bleeding, the contribution of CE to the diagnostic yield is significant; indeed, its accuracy outperforms any other investigational method presently available. [5] [6] Although its value in detecting small bowel Crohn's disease is not as well established, CE has been shown to add diagnostic information, particularly in difficult to determine clinical cases. [7] On the other hand, bowel strictures may cause complications, such as ileus.
To date, published studies either have dealt with small and vaguely defined patient groups [8] or compared CE to obsolete imaging. [9] Prospective comparison of CE with MRI in Crohn's disease is lacking. Therefore, this prospective study aimed at evaluating the efficacy and safety of CE in diagnosing small bowel Crohn's disease in comparison to MRI and doublecontrast small bowel fluoroscopy (enteroclysis). 2003 , all patients were screened, who were admitted to our hospital for evaluating suspected or previously diagnosed but worsening Crohn's disease. Crohn's disease was suspected in the presence of suggestive clinical symptoms (diarrhea, abdominal pain, anorexia, weight loss, rectal bleeding) and biochemical signs of systemic inflammation. Differential diagnoses had been excluded by microbiological stool tests, endoscopy, abdominal ultrasound, and cross-sectional imaging. Eighty-one such consecutive patients were identified. They underwent a basic diagnostic work-up at our clinic including abdominal ultrasound, upper endoscopy (optional in established Crohn's disease if performed previously), and ileo-colonoscopy. Patients were asked to take part in the study if these tests did not establish a diagnosis other than Crohn's disease, or -in patients with previously established Crohn's disease -did not sufficiently explain the clinical situation. Moreover, patients were selected in whom the detection of small bowel involvement was thought to potentially affect treatment strategies.. Exclusion criteria were dysphagia, gastrointestinal obstruction and / or ileus, pregnancy, and the presence of an implanted electro-medical device (cardiac pacemaker, defibrillator), and patients under the age of 18 were excluded. The study protocol was evaluated and approved by the ethics committee of the Medical Faculty of the Martin-Luther-University. Written informed consent was given by all patients.
Methods

S
Imaging procedures
The technique of CE has been described in detail elsewhere. [10] After an overnight fast, patients ingested 1500 to 2000 ml of a bowel purgative (Klean-Prep ®, Norgine, Marburg, Germany). Simethicone (80mg of Espumisan® Emulsion, Berlin-Chemie, Germany) was given with a small amount of tap water (<20ml) about twenty minutes prior to capsule ingestion. [11] Patients were allowed to drink water after two hours but not to eat until four hours later and were encouraged to walk around if they were able to. Digital video films of the examinations were reviewed using the 'Rapid Reader 2'-software (Rapid Reader®, Given Imaging, Yoqneam, Israel To exclude bowel strictures, enteroclysis and/or MRI were performed prior to CE. Significant bowel stricture was defined as luminal narrowing to less than 12mm. CE was not performed in these cases. The examiners of CE, MRI, and enteroclysis were blinded to each others findings, but were aware of the patients' history and laboratory data.
The primary event of interest was the detection of an inflammatory lesion of the small bowel. In addition, complications, patients' acceptance of the diagnostic methods, and final diagnosis after twelve months follow-up were investigated. In CE, the detection of aphthous mucosal lesions, irregularly shaped or fissural ulcersoccasionally associated with bleeding -, cobblestone appearance, luminal narrowing due to edema and / or fibrous scarring, and granularity with attenuated or lost vascular pattern resulted in the diagnosis of Crohn's disease ( figure 1 ). On the other hand, findings such as patchy mucosal erythema, edema, or a single regular ulceration were considered inconclusive. MRI features indicative of active small bowel Crohn's disease included thickening of the bowel wall ( ≥ 4mm) and enhancement of the bowel wall after application of intravenous contrast medium (figure 2). In contrast, weak enhancement of bowel loops without bowel wall thickening was interpreted as an nonspecific finding. All investigations were accomplished within ten days with the exception of one patient (six weeks). Patient comfort during the imaging procedures was determined by use of a questionnaire which was to be completed within five days of the procedure. Patients were asked to grade "stress" on a scale of 0 (no stress at all) to 10 (unbearable stress) for each of the imaging procedures (MRI, CE, and enteroclysis). None of the patients was on regular NSAID medication. In addition, all patients denied the occasional intake of NSAIDs during the study. Eighty-one consecutive patients were screened for eligibility. In twenty-eight of these patients, either a definitive diagnosis was made by basic procedures, or it was determined that clinical management would not be affected by potential small bowel involvement. In one case, an urgent surgical intervention was necessary. Thus, fifty-two patients were enrolled (female: n = 39, male: n = 13, age 18 to 72 years [mean ±SD: 36.6 ±12.41 years in males and 39.7 ±16.0 years in females]; figure 3).
Twenty-five patients were newly suspected to have Crohn's disease while a diagnosis of Crohn's disease had been previously established in 27. The leading symptom at hospital admission was abdominal pain in 27 / 52 patients (51.9%), diarrhea in 19 (36.5%), and weight loss or perineal fistula with suspected Crohn's disease in 3 patients each (5.8%). In patients with established Crohn's disease the diagnosis had been made at an average of 8 years (range: 6 months to 23 years) previously. Sixteen of these patients had undergone bowel surgery 7 to 172 months before inclusion in the study (mean: 66.5 ±48.34 months). Surgical interventions comprised ileocoecal resection (n = 7), resection for stricture or strictureplasty (5), segmental resection for fistula (2) , and partial colectomy (2).
In patients with an acute flare of established Crohn's disease, enteroclysis detected small bowel lesions in 16 of 27 cases (59.2%). No lesion was found in three cases. High grade bowel stricture was proven by enteroclysis in 12 cases. MRI detected inflammatory small bowel lesions in 22 of 27 patients (81.5%). One patient did not tolerate the procedure of enteroclysis, but MRI detected a high grade bowel stricture. Therefore, CE was not accomplished in thirteen patients due to bowel stricture. In the remaining fourteen, typical features of small bowel Crohn's disease were detected in all but one patient (92.9%). In this patient only non-active, supposedly post-inflammatory 'breaking' of the mucosal folds was reported. In direct comparison, CE found slightly more inflammatory lesions than MRI; the difference was not statistically significant (p>0.05), (table 1). CE was the exclusive diagnostic tool in two patients. In a 23 year old female, ileocolonoscopy showed normal colonic and ileal mucosa, and MRI detected some nonspecific contrast enhancement in pelvic small bowel without thickening of the bowel wall. CE demonstrated fissural and irregular ulcerous lesions, granularity and loss of vascularity of the middle small bowel, and the capsule was retained in a functionally stenotic area for about 30 minutes. Enteroclysis had been previously refused by the patient for radiation exposure. The second patient was a 32 year old male with weight loss of 10 kg. Both enteroclysis and MRI found a non-significant narrowing of the anastomosis that was present after segmental colectomy four years earlier. MRI suggested the luminal narrowing to be non-inflammatory in nature and showed minor contrast enhancement of proximal small bowel without wall No pathology was detected in the remaining patients who were diagnosed as not suffering from Crohn's disease. In CE, small bowel lesions were found in twelve of thirteen patients (92%) and in none of the patients with the diagnosis Crohn's disease finally rejected. Patchy erythema in proximal and distal small bowel segments described by CE in another patient were regarded as nonspecific. In this patient, repeated colonoscopy disclosed ulcerous lesions suggesting active Crohn's disease of terminal ileum and colon. Therefore, results in CE much like in MRI were regarded as false-negative (table 3) . Procedure related events occurred in six patients (CE n = 1, MRI n = 3, and enteroclysis n = 2). Ingestion of the capsule was followed by colicky abdominal pain four hours later in one case. A plain abdominal radiograph showed the capsule in the right lower abdominal quadrant. CE imaging data disclosed inflammatory lesions in the upper small bowel and high-grade luminal narrowing in an inflamed region of the distal small bowel. The capsule was retained proximal of this bowel stricture, but did not cause complete obstruction or ileus. After i.v. corticosteroids were started, symptoms improved but did not resolve until about 72 hours later, when the capsule was excreted. Surgical intervention was not necessary - Twenty-two patients returned the questionnaire; all had been investigated by all three methods. MRI mean ±SD stress grade was 4.4 ±2.95 and was regarded less stressing than enteroclysis (stress grade = 5.6 ±2.38; p=0.02). CE (stress grade = 1.1 ±0.9) was found to be significantly less stress-associated than both MRI and enteroclysis (p<0.001, respectively; figure 4).
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Discussion
To the best of our knowledge, the present study is the first to prospectively compare CE with MRI and double-contrast fluoroscopy (small bowel enteroclysis) in patients with supposed small bowel Crohn's disease. While enteroclysis turned out to be the least sensitive modality, CE was only slightly more sensitive than MRI (12 vs. 10 of 13 in suspected Crohn's disease and 13 vs. 11 of 14 in established Crohn's disease), and this small difference did not achieve statistical significance. One would have to perform a trial on 93 (power 80%, alpha 0,05) or 120 patients (power 90%, alpha 0,05) with Crohn's disease of the small bowel in order to statistically prove or disprove such a small advantage in sensitivity of 14% (92% vs. 78%).
Even if such marginal superiority of CE could be established, it would most probably not alter diagnostic decision making in the individual patient as discussed below.
M
One of the problems inherent in diagnostic studies in small bowel Crohn's disease is the lack of a non-surgical "gold standard" for comparisons. Assuming that the apparently most sensitive method should set the "standard" may be incorrect due to unrecognized falsepositive results. For this reason, we used a combined diagnostic end point composed of all imaging methods including ileocolonoscopy as well as clinical and lab data and the evolution of the diagnosis during follow-up. Thus, our rating of CE, MRI and conventional fluoroscopic enteroclysis was as objective as possible.
Another potential source of error in such studies is the observation of nonspecific lesions even in healthy subjects which could be falsely diagnosed as indicative of Crohn's disease. We tried to avoid this problem by defining as narrowly as possible the distinction between "nonspecific" and "diagnostic" for Crohn's disease on the basis of our previous experience with CE und MRI, and of findings described in the literature. Furthermore, investigators were blinded for the results of the various competing imaging methods. Finally, our present results were obtained in a highly preselected group of patients. However, there is no apparent reason to assume that the hierarchy of diagnostic efficacy of the three imaging methods investigated should be substantially altered in a population showing a smaller prevalence of Crohn's disease. If anything, the specificity of positive results of all three methods, possibly most prominently for CE, would decrease if the number of subjects with nonspecific findings were to increase. The results concerning enteroclysis in suspected Crohn's disease might have been hampered by the fact that some patients refused this procedure -mainly due to fear of radiation. While this is correct theoretically, enteroclysis still performed less sensitive than MRI (enteroclysis vs. MRI: p=0.011) and CE (enteroclysis vs. CE: p=0.002) in the subgroup of patients in whom all three methods had been applied. Alike results have been reported [30] : In a trial of 84 patients the sensitivity was 85.4% and 95.2%, and the specificity was 76.9% and 92.6% for enteroclysis and MRI, respectively. Others found similar sensitivities for conventional enteroclysis and MR-enteroclysis in detecting small bowel Crohn's disease. [29] In addition, we believe that refusal to undergo imaging because of problems inherent in the examination itself should not be disregarded when calculating diagnostic efficacy.
In the pre-CE era, results of intraoperative endoscopy of the entire small bowel increased the number of findings over those known pre-operatively in 20 to 35% [13] [14] and influenced surgical interventions in about 60% [15] of patients with Crohn's disease requiring surgical intervention. Information on the comparative diagnostic efficacy of CE in Crohn's disease is sparse to date. In the early more or less anecdotal reports, detection rates of CE are reported as 70% (12 of 17 Crohn lesions) [7] and 42.8% (9 of 21) [16] in patients with an unspecified but apparently non-diagnostic prior investigational work-up. The diagnostic yield of CE in explaining the symptoms of abdominal pain, diarrhea and weight loss was found to be higher (70%) than that of small bowel follow-through and enteric computed tomography (35%) in another study. [17] However, final diagnoses were not given in this report leaving the diagnostic efficacy of CE for Crohn's disease unknown. Other feasibility studies of CE were mostly restricted to patients with suspected Crohn's disease [18] , and CE was not formally compared to other investigations. [19] [20] Enteroclysis or small bowel follow-through have been standard radiological investigations to detect small bowel Crohn's disease until now, but the preference for one or the other still depends on institutional standards. [21] [22] In a very recent study, CE was compared to barium contrast small bowel follow-through (SBFT) in 30 patients with a previously established diagnosis of Crohn's disease. [23] Although active small bowel Crohn's disease was detected in a similar proportion of patients by both methods (CE: 21/30 patients; SBFT: 20/30), findings were inconsistent in 20 -30% of patients: in six patients, CE found lesions that had escaped detection by SBFT, while SBFT was diagnostic in five patients in whom CE had failed. In a retrospective study [24] of 40 patients with CE, 3 were found to have significant small bowel ulceration despite normal fluoroscopic enteroclysis. In the present study, the sensitivity of enteroclysis was found to be significantly inferior to both CE and MRI. Since radiation exposure is significant [25] In conclusion, CE is highly sensitive in diagnosing small bowel Crohn's disease and well tolerated by the patients. It might even be slightly superior to MRI, but this potential advantage is relevant in a few cases in clinical practice only. Imaging of the small bowel in patients with suspected or established Crohn's disease is indicated for the initial determination of the extent of bowel involvement, if a diagnosis cannot be made by upper endoscopy and ileocolonoscopy, and if demonstration or exclusion of small bowel involvement would affect medical or surgical therapy. In this situation, the first, most simple and quite helpful examination is abdominal ultrasound. As the next step, if questions of therapeutic relevance remain, MRI should be performed to provide clues to both intestinal and extraintestinal Crohn's disease, although it might lack the superior sensitivity of CE in detecting minor lesions limited to the mucosa. Using this algorithm, CE will most probably be applicable to no more than 10% of the population in which the small bowel should be group.bmj.com on October 30, 2017 -Published by http://gut.bmj.com/ Downloaded from specifically visualized. In the present trial of 52 patients this applied to four, in whom CE was the only effective diagnostic measure. 
